Analytical similarity, potency, immunoassay, and bioanalytical services for proteins, antibodies, enzymes, hormones, and biosimilar candidates.
Biosimilar and biologics programs require aligned structural, functional, and bioanalytical evidence. rebirthBiology builds assay panels that support similarity narratives and clinical development decisions.
Identity, purity, charge variants, aggregation, glycan-related attributes, and higher-order indicators as applicable.
PK, ADA, neutralizing antibody, and biomarker assays using fit-for-purpose or validated formats.
Functional readouts for mechanism-relevant activity and batch comparison.
Testing strategies that connect bioanalysis, quality control, stability, and comparability packages.
Multiple analytical technologies reduce uncertainty in similarity assessment.
Potency and binding assays are selected around mechanism and clinical relevance.
Reports organize results for technical summaries and regulatory review.
Share reference product, candidate stage, available methods, and target jurisdictions.
Discuss Biosimilar Support